MedPath

Coenzyme M

Generic Name
Coenzyme M
Brand Names
Uromitexan
Drug Type
Small Molecule
Chemical Formula
C2H6O3S2
CAS Number
3375-50-6
Unique Ingredient Identifier
VHD28S0H7F

Overview

Coenzyme M (commonly known by its salt form, Mesna) is a synthetic sulfhydryl (thiol) compound and is used for prophylaxis of Ifosfamide and cyclophosphamide induced hemorrhagic cystitis.

Background

Coenzyme M (commonly known by its salt form, Mesna) is a synthetic sulfhydryl (thiol) compound and is used for prophylaxis of Ifosfamide and cyclophosphamide induced hemorrhagic cystitis.

Indication

Mesna is a uroprotective agent and is used prophylactically to reduce ifosfamide and cyclophosphamide induced hemorrhagic cystitis.

Associated Conditions

  • Hemorrhagic cystitis caused by cyclophosphamide
  • Hemorrhagic cystitis caused by ifosfamide

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/07/04
Not Applicable
Not yet recruiting
2025/04/24
Early Phase 1
Not yet recruiting
C17 Council
2025/02/26
Phase 2
Recruiting
2025/02/19
Phase 1
Recruiting
2025/01/16
Phase 1
Recruiting
2024/11/07
Phase 1
Suspended
2024/04/03
Phase 2
Recruiting
2024/03/22
Phase 1
Recruiting
2024/01/05
Phase 1
Withdrawn
James Isaacs, MD
2023/11/07
Phase 1
Recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Gland Pharma Limited
68083-161
INTRAVENOUS
100 mg in 1 mL
10/7/2022
Hikma Pharmaceuticals USA Inc.
0143-9260
INTRAVENOUS
100 mg in 1 mL
5/3/2023
Sagent Pharmaceuticals
25021-201
INTRAVENOUS
100 mg in 1 mL
3/21/2019
Baxter Healthcare Corporation
0338-1305
INTRAVENOUS
100 mg in 1 mL
3/17/2014
Fresenius Kabi USA, LLC
63323-733
INTRAVENOUS
100 mg in 1 mL
4/22/2019
Baxter Healthcare Company
67108-3565
ORAL
400 mg in 1 1
12/17/2018
Baxter Healthcare Corporation
67108-3565
ORAL
400 mg in 1 1
12/17/2018
Baxter Healthcare Corporation
0338-1307
INTRAVENOUS
100 mg in 1 mL
7/24/2018
Baxter Healthcare Corporation
10019-953
INTRAVENOUS
100 mg in 1 mL
3/20/2015
Baxter Healthcare Company
10019-951
INTRAVENOUS
100 mg in 1 mL
7/18/2018

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
UROMITEXAN TABLETS 400 mg
SIN10703P
TABLET, FILM COATED
400 mg
1/25/1999
UROMITEXAN INJECTION 400mg/4ml
SIN05694P
INJECTION
100.0 mg/ml
4/8/1991
UROMITEXAN TABLETS 600 mg
SIN10704P
TABLET, FILM COATED
600 mg
1/25/1999
MESNA STADA® CONCENTRATE SOLUTION FOR INJECTION 400MG/4ML
SIN14991P
INJECTION, SOLUTION, CONCENTRATE
400 mg/4 ml
4/25/2016

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Mesna Injection
国药准字H10950290
化学药品
注射剂
8/31/2020
Mesna Injection
国药准字HJ20160239
化学药品
注射剂
2/27/2021
Mesna Injection
国药准字H20059142
化学药品
注射剂
4/28/2021
Mesna Injection
国药准字H10950007
化学药品
注射剂
8/31/2020
Mesna Injection
国药准字H20093180
化学药品
注射剂
9/26/2023
Mesna Injection
国药准字H20067661
化学药品
注射剂
8/4/2021
Mesna Injection
国药准字H20093181
化学药品
注射剂
9/26/2023
Mesna Injection
国药准字H20067660
化学药品
注射剂
8/4/2021

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath